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Background: Patients with atrial fibrillation (AF) are characterized by emotional distress and
poor quality of life. Little is known about the relation between emotional distress and sub-
jectively reported AF symptoms. Our aims were to compare emotional distress levels in AF
patients with distress levels in the general population and to examine the cross-sectional
and prospective relationship between subjective AF symptom reports and emotional dis-
tress around electrical cardioversion (ECV).
Methods: At baseline, this study included 118 patients with persistent AF planned for ECV
(aged 68±10 years, 60% men) in which depression (BDI), anxiety (STAI), Type D person-
ality (DS14), perceived stress (PSS-10), and AF symptoms (ATSSS) were assessed. The
prospective substudy included 52 patients. Objective AF status was determined by ECG.
Results: AF patients experienced significantly higher levels of anxiety (p< 0.001) and
depression (p<0.001) than age and gender matched persons from the general popula-
tion. Linear regression analyses showed that AF patients with higher depression levels
reported significantly more AF symptoms (β=0.44; p<0.0005) and reported symptoms
to occur with a higher frequency (β=0.51; p< 0.0005) during the AF episode, indepen-
dent of age, sex, cardiac disease, BMI, and physical activity. At 4 weeks follow-up, 56%
of all patients had maintained sinus rhythm. Repeated Measures Linear mixed modeling
showed that these patients reported fewer AF symptoms and a lower frequency of AF
symptoms pre and post-ECV (p=0.04). Also, the course of the number and frequency of
reported symptoms was significantly associated with the change in depression over that
same time period (p<0.0005).
Conclusion: Patients with persistent AF are characterized by emotional distress. Dis-
tressed AF patients, particularly the depressed, report more AF symptoms before and
after ECV. These findings call for increased attention of clinicians to emotional distress in
this patient population.
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INTRODUCTION
Atrial fibrillation (AF) is the most common, multi-etiologic car-
diac arrhythmia characterized by disorganized electrical signal-
ing in and from the cardiac atria, which results in an increased
and irregular heart beat. AF by itself is not life-threatening, but
it does increase the risk of embolic complications, stroke, cog-
nitive impairment, and congestive heart failure (Camm et al.,
2009).
Atrial fibrillation is generally accompanied by a poor quality
of life (QoL) that is substantially lower than in age and gen-
der matched persons from the general population (Hagens et al.,
2004; Lane et al., 2009). Reduced QoL may be related to com-
mon AF symptoms such as fatigue and shortness of breath (Kang,
2006b). Other QoL reducing factors may include the chronic
character of the disease, accompanied by chronic use of med-
ication, medication side effects, the underlying cause of AF, as
well as the frequently occurring rhythm control interventions,
such as electrical cardioversion (ECV) (Thrall et al., 2006),
although symptom alleviation does improve QoL (Smith et al.,
2010).
Studies in cardiac patients, including AF patients, have shown
that emotional distress is related to impaired QoL (Lane et al.,
2001; van den Berg et al., 2005; Ong et al., 2006). Further inves-
tigation of emotional distress in AF patients is generally lacking.
Studies have indicated that anxiety may be more prevalent in AF
patients than depression (Lane et al., 2009), and that both anxi-
ety and depression are rather persistent, with depression being an
important predictor of future QoL (Thrall et al., 2007). The effects
of emotional distress on disease prognosis are yet unclear, with one
study indicating that depression may be related to AF recurrence
after successful ECV, whereas anxiety and the distressed person-
ality may not (Lange and Herrmann-Lingen, 2007). On the other
hand, a recent study demonstrated that Type D personality was
more prevalent in patients with an emotionally triggered stress
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cardiomyopathy (76% Type D) compared to stress cardiomyopa-
thy patients without an emotional trigger (43% Type D) or patients
with myocardial infarction with an emotional trigger (32% Type
D), carefully suggesting that Type D personality may contribute to
the risk of emotionally triggered cardiomyopathy (Compare et al.,
2013).
There is also limited knowledge on the association between
emotional distress and symptomatic burden. Recently, an argu-
ment was made to include subjective symptomatic burden as
an alternative endpoint in clinical AF trials (Darbar and Roden,
2005), since the increased short-term risk of mortality and events
such as stroke in AF patients is small and therefore long follow-
up periods are needed. These hard endpoints do not measure
symptoms, which is what the patient experiences (Darbar and
Roden, 2005), and which are in turn related to AF recurrence
(Darbar and Roden, 2005). In addition, the goal of AF treatment
is often to reduce symptom burden. Patients with higher levels
of emotional distress may report more AF symptoms. One study
in patients with newly diagnosed AF and one in a convenience
sample of AF patients with concomitant cardiovascular disease
or lone AF showed that emotional distress was positively asso-
ciated with the reported severity of AF symptoms (Kang, 2006a;
Ong et al., 2006). In addition, Sears and colleagues showed that
the number of reported AF symptoms were mostly influenced
by the distress state of patients, and to a lesser extent by objec-
tive indicators of AF (Sears et al., 2005). However, anxiety and
depression were transformed into one “negative emotions” vari-
able in this study, potentially precluding differential effects of
anxiety and depression on symptom reports. In addition, a call
was made for additional studies to be carried out as the above-
mentioned study used a highly selected sample of AF patients
fitted with an implantable cardioverter defibrillator with atrial
therapies.
Therefore, the objectives of the current study were (1) to
determine the prevalence of emotional distress, including anxiety,
depression, distressed (Type D) personality, and perceived stress,
in patients with persistent AF during an AF episode, and to com-
pare these emotional distress levels with levels in an age and gender
matched sample from the general population, (2) to examine the
association between emotional distress and subjective report of
AF symptoms during an AF episode, and (3) to study the effects of
emotional distress on the changes in subjective symptom reports
from before to 4 weeks after ECV.
MATERIALS AND METHODS
PATIENT POPULATION
Between October 19, 2007 and March 4, 2009 a total of 205 patients
diagnosed with persistent AF and eligible for ECV presented at the
Cardiology clinic of the TweeSteden hospital for an elective ECV to
restore their sinus rhythm (SR). Of these, 124 agreed to participate
in the current survey study by returning the questionnaire before
cardioversion. Patients who declined to participate did not differ
from participants of the study with regard to gender (p= 0.52)
or age (p= 0.50). Patients (n= 6) with AF due to cardiac surgery
or valvular dysfunction were excluded from analysis (final sam-
ple n= 118). A substudy examined the course of AF symptoms
from before to 6 weeks after the cardioversion. Fifty-two patients
participated in this substudy. AF status at inclusion and follow-up
were determined by ECG. The study protocol was approved by the
hospital’s local medical ethics committee in Tilburg, Netherlands
(METOPP) as this behavioral study was not subject to the Medical
Research Involving Human Subjects Act (WMO). The study was
conducted conform to the most recent version of the Helsinki Dec-
laration (2008) and all patients provided written informed consent
prior to participation.
GENERAL POPULATION
We matched the AF patients to healthy control subjects with
respect to gender and age. The healthy controls were drawn from
a random selection of 2419 adults from the general Dutch pop-
ulation that had participated earlier in a large survey study on
psychological and physical health, and for which data on Type D
personality (DS14), state anxiety (STAI), and depression (BDI)
were present. We used participants’ self-report on medical diag-
noses (e.g., “Do you have high blood pressure?” “Do you have a
respiratory disease?”) to establish that they were healthy. Informa-
tion on how these data were collected has been published previ-
ously (Mols et al., 2009). All participants signed written informed
consent and the university ethics committee approved the study
protocol.
SOCIO-DEMOGRAPHIC AND CLINICAL VARIABLES
Socio-demographic information was obtained via self-report and
included gender, age, education, and marital status. Smoking
status, alcohol use, physical activity status, and anthropometric
characteristics were also assessed by means of self-report. Clinical
variables were obtained from medical records and included co-
morbid (previous thromboembolism, stroke, transient ischemic
accident, cancer, peripheral arterial disease, and renal insuffi-
ciency) and concomitant (hypertension, coronary artery disease,
heart failure, valvular heart disease, cardiomyopathy, sick sinus
syndrome, COPD, and thyroid disease) diseases, current medica-
tion use, previous cardioversions (electrical and pharmacological),
and successfulness of the ECV at follow-up.
SUBJECTIVE AF SYMPTOM REPORT
The Atrial Tachyarrhythmia Symptom Severity Scale (ATSSS)
(Maglio et al., 1998; Dorian et al., 2000) is a 16-item question-
naire asking the patient to report which AF symptoms have been
experienced over the past 4 weeks, along with the frequency and
severity of the experienced AF symptoms. The frequency of symp-
toms was rated on a 5-point Likert scale from 1 (never) to 5 (all
the time). We used two scores: (1) the total number of symptoms
reported (range 0–16); (2) total AF symptom frequency score,
i.e., the summation of the rated frequency of all 16 items (range
16–80).
PSYCHOLOGICAL ASSESSMENT
Patients completed a psychological survey in the week before the
ECV, and at on average 4.5 weeks thereafter (coinciding with the
follow-up visit at the clinic). Patients were informed about the
study by their attending cardiologist and received an information
letter, informed consent form, and the psychological questionnaire
in a closed envelope. When willing to participate, patients filled out
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the questionnaire and brought the questionnaire and the signed
consent form with them to the cardioversion appointment. The
follow-up questionnaire came with a pre-stamped, self-addressed
envelope the patients were asked to use to return the filled out
questionnaire.
EMOTIONAL DISTRESS
Depression
Depressive symptomatology was assessed with the 21-item Beck
Depression Inventory (BDI-I) (Beck and Steer, 1993). Each item
is rated on a 0–3 Gutmann scale. A total score is obtained by sum-
ming together all items. Total scores range from 0 to 63, with scores
above 10 indicating at least mild levels of depression (Beck and
Steer, 1993). The BDI is a reliable and well-validated measure of
depressive symptomatology (Beck et al., 1988), and is a widely used
self-report measure of depression in patients with cardiovascular
disease.
Anxiety
State anxiety was assessed by the 20-item State subscale of the
Spielberger State Trait Anxiety Inventory (STAI) (Ploeg van der
et al., 1980; Spielberger, 1983). All items are rated on a 4-point Lik-
ert scale from 1 (not at all) to 4 (very much so),with a score range of
20–80. Positively stated items (n= 10) were reversed before sum-
ming. A high score indicates high levels of anxiety, with a score
≥40 indicating probable levels of clinical anxiety (Ploeg van der
et al., 1980; Spielberger, 1983). The STAI is a valid and reliable
scale, with Cronbach’s α ranging from 0.87 to 0.92 (Ploeg van der
et al., 1980).
Perceived stress
The Perceived Stress Scale (PSS) is a 10-item questionnaire mea-
suring of the degree to which, over the past month, life situations
may be appraised as stressful (Cohen and Williamson, 1988).
Answers are given on a 5-point Likert scale from 0 (never) to 4
(very often). PSS scores are obtained by reversing responses to
the four positively stated items and then summing across all scale
items (Cohen and Williamson, 1988). In the current sample, PSS
had good psychometric properties, with Cronbach’s alpha being
0.82.
Distressed personality (Type D)
Type D personality reflects the general tendency to experience neg-
ative emotions, while at the same time inhibiting these emotions
in social situations. Type D personality was assessed by the DS14
(Denollet, 2005), consisting of 14 items that are divided into two
subscales measuring two stable personality traits, negative affec-
tivity (NA; tendency to experience negative emotions across time
and situations), and social inhibition (SI; tendency to inhibit the
expression of negative emotions in social interaction). The items
are answered on a 5-point Likert scale ranging from 1 (false) to 4
(true). Scores on the two positively worded items in the SI sub-
scale were reversed before summing. A standardized cut-off ≥10
on both subscales indicates Type D caseness. The two subscales
have good psychometric qualities, with Cronbach’s α= 0.88/0.86
and 3 month test-retest reliability r= 0.72/0.82 for the negative
affectivity and social inhibition subscale, respectively (Denollet,
2005).
STATISTICAL ANALYSIS
Baseline characteristics were calculated using descriptive statis-
tics [means (SD) and frequencies]. Pearson correlations were used
to calculate the relation between continuous emotional distress
scores and AF symptom number and frequency scores. Point-
biserial (Pearson) correlations were used to assess the correlation
of the symptoms scores and the dichotomous Type D personality
score. Student t -tests for independent samples were used to assess
differences between the AF patient group and the general popula-
tion sample and paired t -tests were used to examine change in the
report of individual AF symptoms before and after ECV, as well
as differences in emotional distress levels and subjective symptom
reports between patients still in SR at 4 weeks after ECV versus
patients that had reverted to AF rhythm.
Covariates
Since age and gender related differences have been reported in
relation to AF (Rich, 2009; Volgman et al., 2009), and obesity
(Lavie et al., 2009) and physical exercise (Rich, 2009) have been
associated with AF as well, we included age, gender, BMI, and
engagement in physical activity in the multiple regression analy-
ses. We also included concomitant cardiovascular diseases CAD
and CHF as covariates, as we also wanted to discriminate between
AF patients with and without concomitant cardiovascular disease.
In the mixed linear modeling analysis for repeated measures we
only included the significant covariates from the cross-sectional
regression analysis.
Multiple linear regression analyses examined the influence
of the various measures of emotional distress on subjectively
reported AF symptoms in the presence of the priori selected
covariates.
The mixed linear modeling procedure in SPSS 17.0.3 (SPSS
Inc. Chicago, USA) was used to examine the effects of emotional
distress on the change in number and frequency of reported AF
symptoms before and 4 weeks after ECV while taking into account
the successfulness of the ECV and significant covariates from the
multiple regression analysis. This technique is suitable for analy-
sis of repeated measurements, as it reckons with the possibility
of correlated data. In addition, in contrast to traditional repeated
measures analysis of variance, one missing measurement occa-
sion does not automatically lead to exclusion of that patient from
analysis, limiting bias and preserving statistical power. All cases
are therefore used in the mixed modeling analysis. Data was first
restructured by the variables to cases procedure such that per
patient consecutive AF symptom reports and emotional distress
measurements (baseline and follow-up) constituted a case. We
further used an unstructured covariance matrix, so that no a pri-
ori assumptions were made about the relatedness of the follow-up
data. Then, we performed two analyses, one for the number of
reported AF symptoms and one for the frequency of the reported
AF symptoms (dependent variables). Each analysis consisted of
three steps. In the first step, we added time and maintenance of SR
as factors. Next, we added the significant covariates from the lin-
ear regression as constant covariates. Finally, all emotional distress
measures (depression, anxiety, and perceived stress) were entered
as time-varying continuous factors. All analyses were two-tailed
and a p value of <0.05 was considered significant.
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RESULTS
PATIENT CHARACTERISTICS
Table 1 shows the baseline patient characteristics. The majority of
the patients was male (62%) and patients were on average 68 years
of age. Approximately half of the sample had concomitant cardiac
disease, while the other half had lone AF or AF with hypertension.
Sixty percent of patients had a previous ECV or pharmacologi-
cal intervention before inclusion into the current study. Due to
the short follow-up time, at 4 weeks follow-up only half of the
sample (n= 52) had returned their follow-up questionnaire. t -
Tests and chi square tests showed that those who participated
only once did not differ from those who participated twice on
baseline characteristics including age (t =−1.5, p= 0.13), gender
(χ2= 3.6, p= 0.06), number (t = 0.7, p= 0.45), and frequency
(t = 0.9, p= 0.40) of reported symptoms, maintenance of SR
at follow-up (χ2= 2.1, p= 0.15) and levels of emotional dis-
tress (anxiety: t =−1.4, p= 0.18; depression: t =−0.3, p= 0.97;
perceived stress: t = 0.6, p= 0.79; Type D personality: χ2= 0.3,
p= 0.59).
SUBJECTIVE AF SYMPTOM REPORT
During the AF period, patients reported the presence of on average
9.3 (±4.1) symptoms (out of 16), with a frequency of on average
2.5 (±0.5; range 2–4) for those symptoms that were reported to
be present. Table 2 shows the prevalence and the mean frequency
for each subjective AF symptom, both at baseline and 4 weeks
follow-up. The majority of patients reported symptoms of tired-
ness, dyspnea and tachycardia, while the least reported symptoms
were nausea, poor appetite and chest pain in absence of tachy-
cardia. Paired t -tests showed that patients reported significantly
less heart racing 4 weeks after cardioversion and reported trend
reductions in heart fluttering or beat skipping and accompanying
chest pain (Table 2). Of note, there were no gender differences
in the number or frequency of reported AF symptoms before or
after ECV.
COMPARING EMOTIONAL DISTRESS IN AF PATIENTS WITH MATCHED
HEALTHY CONTROLS
Emotional distress levels were relatively high in the patients with
persistent AF (see Table 3, left panel). Levels in AF patients were
significantly higher in comparison to the matched healthy con-
trol group (for depression: 8.6± 7.1 versus 5.6± 4.5; t =−4.22,
p< 0.001; for anxiety: 37.5± 12.1 versus 32.2± 7.4; t =−3.80,
p< 0.001). A significantly larger number of AF patients (33%)
showed signs of clinically significant depression compared to
healthy controls (13%; χ2= 10.72, p= 0.001). Similar findings
were found for anxiety, as 42% of AF patients reported clinically
relevant levels of anxiety compared to 11% of the healthy controls
(χ2= 20.85, p< 0.001).
Type D personality prevalence was 28% in AF patients, which
was to be expected in a cardiac patient population (Kupper and
Denollet, 2007). Type D personality prevalence in the healthy
controls was lower, with a prevalence of 17% (χ2= 3.48, p= 0.06).
SUBJECTIVE SYMPTOM REPORTS DURING THE AF EPISODE AND
EMOTIONAL DISTRESS
The correlations presented in Table 4 show that depression,
anxiety and perceived stress, but not Type D personality, were
Table 1 | Patient characteristics.
Persistent AF (N =118)
DEMOGRAPHICS
Age (years) Mean±SD 68.0 (±9.4)
Female gender 38.8% (38)
Time since diagnosis (years) Mean±SD 3.8 (±4.6)
CONCOMITANT DISEASE
Hypertension 46.6% (55)
Coronary artery disease 35.6% (42)
Heart failure 12.7% (15)
Valvular heart disease 3.4% (4)
Cardiomyopathy 6.8% (8)
Sick sinus syndrome 1.7% (2)
COPD 7.6% (9)
Thyroid disease 7.6% (9)
Idiopathic disease 44.1% (52)
CARDIOVASCULAR RISK FACTORS
Diabetes 12.7% (15)
Hyperlipidemia 35.9% (42)
Smoking 10.9% (11)
Lack of exercise 54.6% (56)
Family history of CAD 32.1% (36)
COMORBIDITIES
Previous thromboembolism 2.5% (3)
Stroke 3.4% (4)
TIA 3.4% (4)
Cancer 6% (7)
Peripheral arterial disease 5.9% (7)
Renal insufficiency* 26.1% (26)
PREVIOUS INTERVENTIONS
Pharmacological cardioversion 8.4% (10)
Electrical cardioversion 51.8% (60)
Catheter ablation 0%
ICD implantation 3.4% (4)
Surgery for AF 1.7% (2)
DRUGTHERAPY AT STUDY INCLUSION
Antithrombotic
Oral anticoagulation 98% (115)
Anti-arrhythmic/rate control
Type Ia 8% (9)
Type Ic 8% (9)
Type II 44% (51)
Type III 55% (64)
Type IV 11% (13)
Digoxin 21% (24)
Other
ACE inhibitor 33% (39)
ARB 17% (20)
Beta-blocker (other than Type II) 3% (3)
Diuretic 30% (35)
Spironolactone 7% (8)
Statin 39% (46)
*Based on glomerular filtration rate of creatinine, using the MDRD formula.
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Table 2 | Prevalence and mean frequency of the individual subjective AF symptoms.
AF symptom Prevalence
during AF
episode (%)
Mean frequency
(SD) during AF
episode*
Prevalence at
follow-up
Mean frequency
(SD) at follow-up
Tiredness/lack of energy 92 3.0 (1.0) 92 2.8 (1.1)
Shortness of breath 76 2.8 (0.9) 71 2.6 (0.9)
Hard to catch breath 75 2.6 (0.9) 67 2.6 (0.9)
Heart racing 70 2.9 (1.0) 48 2.5 (0.9)*
Heart fluttering, skipping 69 2.9 (1.0) 46 2.5 (0.9)†
Weakness 63 2.5 (0.8) 52 2.3 (0.6)
Sweating 63 2.5 (0.7) 47 2.3 (0.6)
Trouble concentrating 62 2.4 (0.7) 68 2.3 (0.6)
Light-headedness/dizziness 62 2.4 (0.7) 59 2.3 (0.7)
Difficulty sleeping 58 2.7 (0.8) 65 2.5 (0.7)
Chest pain, pressure or fullness when heart is racing or fluttering 52 2.3 (0.6) 46 2.2 (0.5)†
Headache 46 2.4 (0.7) 44 2.7 (1.0)
Feeling warm, flushed 44 2.4 (0.7) 40 2.2 (0.5)
Chest pain, pressure or fullness when heart is not racing or fluttering 32 2.3 (0.7) 35 2.0 (0.0)
Poor appetite 31 2.6 (0.9) 27 2.5 (0.8)
Nausea 24 2.3 (0.7) 27 2.1 (0.3)
Total scores Mean total Mean total
Number of reported symptoms 9.0 (4.0) 8.3 (3.4)
Frequency of reported symptoms 30.7 (9.1) 28.4 (8.1)
Frequency of AF symptoms is rated from 1 (never) to 5 (all the time). A symptom is present when a score of 2 or higher is recorded. *Mean frequency was determined
for patients that reported the symptom to be present [2 (some of the time) – 5 (all the time)]. Paired t-tests were done on the original frequency variables [including
1 (absence of symptom)]; *Significant reduction (p<0.05) † trend reduction (p<0.10).
Table 3 | Prevalence of emotional distress during the AF episode and after sinus rhythm had been restored.
Emotional distress During AF
episode (n=118)
After ECV
Sinus rhythm at
4 weeks FU (n=31)
AF rhythm at
4 weeks FU (n=21)
Mean (SD) % Mean (±SD) % Mean (±SD) %
Type D personality – 28 – – – –
Depression 8.6 (6.8) 32.7 8.1 (5.1) 29.0 9.1 (5.3) 38.1
Anxiety 37.5 (12.1) 42 37.7 (9.7) 36.7 38.4 (13.8) 50.0
Perceived stress 15.8 (7.9) 15.3 (6.2) 15.4 (7.9)
ECV, electrical cardioversion; AF, atrial fibrillation; FU, follow-up.% Depression,% Anxiety: percentage of patients scoring above a predefined threshold for clinically
relevant depression and anxiety.
highly related to the number as well as the frequency of reported
symptoms of AF. Linear regression analyses showed that depres-
sion (βnumber= 0.58, p=< 0.001; βfrequency= 0.52, p< 0.001),
anxiety (βnumber= 0.35, p= 0.002; βfrequency= 0.28, p= 0.008),
and perceived stress (βnumber= 0.41, p< 0.001; βfrequency= 0.32,
p= 0.003) were all significantly related to respectively the num-
ber and the frequency of reported AF symptoms during the AF
episode, independent of the a priori selected covariates (Table 5).
When entering all measures of emotional distress into one
regression analysis, including the a priori selected covariates, only
depression remained a significant associate of both the number
and frequency of reported AF symptoms (Table 5). In this multi-
variate model, physical activity and CAD were other associates of
the number and frequency of AF symptoms, with more and more
frequent report of symptoms in patients with CAD and in patients
that performed regular physical exercise at least once a week.
Multicollinearity diagnostics showed that tolerance was accept-
able (>0.47), making multicollinearity improbable and justifying
the inclusion of the three emotional distress measures together in
one analysis.
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Table 4 | Relation of emotional distress with the number and frequency of reported AF symptoms during the AF episode and 4 weeks post-ECV.
During AF episode (n=118) 4 weeks post-ECV (n=52)
Number of AF symptoms Frequency of AF symptoms Number of AF
symptoms
Frequency ofAF
symptoms
SR AF SR AF
Type D personality 0.08 0.12
Depression 0.53*** 0.55*** 0.39* 0.38 0.46* 0.50*
Anxiety 0.30** 0.26** 0.60** 0.36 0.59** 0.40†
Perceived stress 0.37*** 0.29** 0.39* 0.39† 0.36† 0.43†
SR, patients still in sinus rhythm 6 weeks post-ECV; AF, patients that relapsed into AF rhythm 4 weeks post-ECV.
† = trend (p<0.10), *=p<0.05, **=p< 0.01, ***=p<0.001.
Table 5 | Multivariable regression analyses on the effects of emotional distress on the number and severity of reported AF symptoms during the
AF episode.
During AF episode (n=118)
Number of AF symptoms Frequency of AF symptoms
β P R2 β P R2
MODEL 1
All covariates* 0.11 0.07
CAD 0.22 0.04 0.25 0.03
Physical activity 0.18 0.09
MODEL 2
+Depression, anxiety &
perceived stress*
0.44 0.32
CAD 0.18 0.051 0.20 0.046
Physical activity 0.22 0.02
Depression 0.45 <0.0005 0.54 <0.0005
State anxiety 0.04 0.74 0.005 0.97
Perceived stress 0.07 0.59 −0.01 0.93
*Covariates in the model: presence of cardiovascular disease (CAD, CHF), BMI, age, gender, and physical activity. Only significant (or trend) covariates are shown in
step 1.
Bold faced: significant (p<0.05) relations in the model.
DETERMINANTS OF THE CHANGE IN NUMBER AND FREQUENCY OF
SUBJECTIVE SYMPTOMS
Four weeks after the ECV, 56% of patients were still in SR.
Number of symptoms
Linear mixed modeling of the repeated assessments of the
AF symptom reports and the emotional distress questionnaires
showed that the baseline and post-ECV symptom reports did not
differ significantly from each other, as there was no effect of time
(Table 6).
Change in reported number of symptoms before and after ECV
was significantly affected by the maintenance of SR at 4 weeks
follow-up (assessed with ECG), with patients in SR at follow-
up reporting on average fewer AF symptoms than patients that
had reverted to AF rhythm (Mean difference=−1.7). The sec-
ond step included adding both covariates, which did not affect
the influence of the successfulness of the ECV on the number
of reported symptoms. Engaging in physical activity at baseline
was associated with the report of fewer AF symptoms over the
assessment period (p= 0.01). In a final step, the three emotional
distress measures were added. Results showed that the course of
depression over the assessed time period was a significant deter-
minant of the change in the reported number of AF symptoms
over this period (p< 0.0005), meaning that with a larger change
in depression score, a larger change in the number of AF symp-
toms occurred, i.e., for each 1 point increase of the depression
score, the reported number of symptoms increased with 0.30 (see
Table 6). Anxiety and perceived stress were not significant in this
final model, indicating that changes in anxiety and stress were
unrelated to changes in the number of AF symptoms.
Frequency of symptoms
The reported frequency of AF symptoms was not associated with
the time of assessment (before or after ECV; see Table 6 right
panel). The change in reported frequency of AF symptoms over
time was significantly affected by the maintenance of SR as assessed
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Table 6 | Associates of change in the reported number and frequency of AF symptoms before and after ECV.
Number of AF symptoms Frequency of AF symptoms
Estimate SE t p Estimate SE t p
MODEL 1
Time 0.33 0.56 0.6 0.56 1.53 0.94 1.6 0.11
AF status at FU −1.7 0.81 −2.1 0.04 −3.7 1.81 −2.1 0.04
MODEL 2
Time 0.31 0.60 0.5 0.61 1.76 1.01 1.7 0.09†
AF status at FU −1.7 0.83 −2.1 0.04 −3.8 1.95 −1.9 0.056†
Presence of CAD −1.0 0.77 −1.3 0.19 −3.2 1.8 −1.7 0.09†
Physical activity −2.0 0.77 −2.5 0.01 −1.5 1.84 1 0.41
MODEL 3
Time 0.03 0.62. 0.1 0.96 1.37 1.18 1.2 0.25
AF status at FU −1.3 0.88 −1.5 0.15 −2.43 1.88 −1.3 0.20
Presence of CAD −0.7 0.81 −0.9 0.38 −1.12 1.71 −0.7 0.52
Physical activity −2.5 0.83 −3.0 0.004 −3.48 1.8 −1.9 0.06†
Depression 0.30 0.08 3.9 <0.0005 0.74 0.16 4.5 <0.0005
Anxiety 0.03 0.04 0.7 0.46 0.07 0.09 0.8 0.43
Perceived stress −0.03 0.07 −0.5 0.62 −0.13 0.14 −0.9 0.36
SE, standard error; FU, follow-up; CAD, coronary artery disease; boldfaced, p<0.05; †, trend (p<0.10). Estimate can be interpreted as a unstandardized linear regres-
sion coefficient, meaning that 1 point increase in, e.g., depression from baseline to follow-up will lead to an [estimate] increase/decrease in the number/frequency of
AF symptoms over that time period.
by ECG-confirmed AF status at follow-up, with patients in SR at
follow-up reporting AF symptoms with a lower frequency both
before and after ECV than patients that had reverted to AF rhythm
(Mean difference=−3.7). Adding both covariates to the model
reduced the effect of the successfulness of the ECV to trend level. In
the final step we added the measures of emotional distress. Results
showed that the course of the reported frequency of AF symptoms
was significantly associated with change in depression over this
time period, i.e., with 1 point increase in depression score, the AF
frequency report also increased 0.75 points (Table 6). Anxiety and
perceived stress were not significant in this final model, indicating
that changes in anxiety and stress were unrelated to changes in the
frequency of AF symptoms.
DISCUSSION
The objective of the current study was to compare emotional
distress levels in AF patients with distress levels in the general
population and to examine the relationship between subjective
AF symptom reports and emotional distress before and after ECV.
Our findings led to two primary conclusions. First, emotional dis-
tress levels were substantially higher in the AF group than in the
matched sample from the general population and second, higher
levels of emotional distress in patients with persistent AF were sig-
nificantly associated with the report of more AF symptoms during
an AF rhythm episode, but also with the change of the report of
AF symptoms after ECV. Maintenance of SR after ECV also was an
important determinant of the subjective AF symptom report, but
to a lesser extent than depression.
Depression was the strongest associate of reporting a larger
quantity and a higher frequency of AF symptoms during the
AF episode, independent of several covariates, including gender,
presence of concomitant cardiovascular disease and physical activ-
ity. Our results build on previous research demonstrating negative
emotions to be associated with a greater number (Sears et al.,
2005) and frequency (Kang, 2006a; Ong et al., 2006) of subjective
AF symptoms. Most symptoms of AF originate from the increased
heart rate induced by disorganized AF conduction, which may be
perceived as chest discomfort. Inadequate blood flow and oxy-
gen delivery may be a consequence of rapid heart rate, and may
induce symptoms of fatigue, shortness of breath, light-headedness,
edema, and fainting. Nevertheless, the above described symptoms
are also perceived by AF patients in the absence of AF rhythm. The
depression associated risk for increased report of AF symptoms
may in part be explained by the cognitive-affective processing asso-
ciated with depressive symptomatology, such as rumination and
heightened attentional focus on bodily sensation, may influence
the report of somatic complaints (Barsky et al., 1988; Howren et al.,
2009). Future research may want to focus on methods to reduce the
body-centered attentional bias in patients with AF and emotional
distress. Frequent asking for symptom reports though, may also
have an adverse effect, as patients may become more self-focused
because you ask to report about bodily sensations.
Clinically, physicians could screen for depressive or anxious
symptomatology to be able to refer highly distressed AF patients
to a medical psychologist. Cardiologists should take more time
answering questions from anxious patients, which might be
accomplished within time constraints by implementing a patient-
centered approach of cardiologic care (Jayadevappa and Chhatre,
2011). Psychologists should treat the depression according to pre-
vailing guidelines and additionally focus on reducing the atten-
tional bias toward bodily sensations. There are some techniques
that may help, including mindfulness training, which has shown
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to be able to divert attentional focus (Kee et al., 2012). More-
over, informing patients about the unknown may also alleviate
anxiety symptoms as is seen other patient groups (e.g., surgery
patients: Bellani, 2008), but still has to be investigated in patients
with AF.
Despite initially successful ECV, about 50% of patients had a
recurrence at 4 weeks follow-up, which is a normal success rate
(Arya et al., 2010). Our results showed significant and stable dif-
ferences in the level of reported AF symptoms (both number
and frequency) between patients who reverted to AF rhythm and
patients that had maintained SR, although in the full model, part
of this association was explained by differences in depression. We
further observed that subjective symptomatic burden of AF did
not wane much after ECV in both patient subgroups. In paroxys-
mal AF it is common that subjective reports of AF symptoms are
not in concordance with the real arrhythmic events (Atarashi et al.,
2008), and our results suggest that this is also the case in patients
with persistent AF. Both maintenance of SR after ECV and change
in depression score over the assessment period significantly influ-
enced the course of the reported number and frequency of AF
symptoms.
In comparison to the general population, patients with persis-
tent AF experienced higher levels of emotional discomfort, mani-
fested in increased reports of depression, and anxiety, and a higher
prevalence of Type D personality. In addition, higher percentages
of AF patients scored above the predefined threshold for clini-
cally relevant depression and anxiety. These findings corroborate
previous comparisons between patients with other cardiovascu-
lar diseases (stroke, hypertension, coronary heart disease) and the
general population, showing increased levels of emotional dis-
tress across the cardiovascular disease spectrum (Denollet, 2005;
Baune et al., 2006). This also confirms several previous reports
that showed anxiety levels to be higher in elderly patients with
AF as compared to control patients free of cardiac arrhythmia
(Thrall et al., 2007; Perret-Guillaume et al., 2010). With regard
to depression, studies have reported a higher (Perret-Guillaume
et al., 2010) or equal prevalence (Thrall et al., 2007) in AF patients
as compared to control patients. The number of patients actually
presenting clinically significant levels of anxiety and depression is
disturbingly high (between 30 and 50%), and should be a focus
point for clinicians and medical psychologists. Clinically, it is
thus of importance to address patients’ emotional distress, as a
cardioversion might not lead to the expected symptom relief in
those patients reporting high levels of emotional distress. Future
research should examine whether a similar effect may be observed
in patients that are treated with other rhythm therapies, or rate
therapy. Moreover, longitudinal studies that employ ambulatory
monitoring of AF rhythm should be set up, to examine the role
of psychological factors on recurrence of AF episodes in patients
with paroxysmal AF episodes. In case of persistent AF episodes
terminated by ECV, studies should focus on psychophysiological
intermediary processes that may explain ECV success rates, such
as sympathetic nervous system activation.
Previous research has shown that there are gender differences
in AF prognosis, favoring men with respect to mortality, heart
failure, and stroke incidence. Women also tend to be more symp-
tomatic than men, do worse after rhythm control strategies with
anti-arrhythmic medication and have a poorer QoL (Dabrowski
et al., 2010; Michelena et al., 2010). The current investigation in
persistent AF patients however did not find any gender differences
in the number of reported AF symptoms as well as the reported
frequency with which the AF symptoms occurred, both before
and after ECV, a rhythm control intervention. Also, there were
no gender differences in the ECG-confirmed AF status 4 weeks
after ECV.
Our findings should be viewed in light of several limitations.
The attrition rate in our study was unexpectedly high. Approxi-
mately half of the included patients were not willing to fill out the
second questionnaire, potentially due to the length of the ques-
tionnaire which also contained other questionnaires and the short
follow-up time of 4 weeks, in spite of the extensive letter explain-
ing the importance of repeated measurements for our research
questions. Because of this attrition rate, we cannot be certain that
patients who dropped out of the study would have demonstrated
the same relations over time, although there were no baseline
differences between patients who dropped out of the study and
patients that completed the two measurements. A further limita-
tion is our relatively small sample size, which prevented us from
including a larger number of covariates. Nevertheless, strengths
of our study include the prospective design of the study and the
assessment of emotional distress both during AF and after ECV
had restored the SR, because this gives insight into the intricate
relations between emotional distress, objective AF status and sub-
jective AF symptom reports, and provides ideas for future research.
For example, future research could examine whether reducing
attentional self-focus affects the number and frequency of reported
AF symptoms and whether this affects successfulness of the ECV.
Moreover, it should be tested whether emotional distress is a trig-
ger of AF episodes and which psychophysiological processes play
a role.
In conclusion, emotional distress is highly prevalent among
persistent AF patients and is strongly associated with the number
and frequency of reported AF symptoms, independent of gender,
concomitant cardiac disease, and cardiovascular risk factors. The
subjective symptomatic burden of AF did not wane much after
cardioversion, and was significantly determined by the course of
depression during this period. These findings call for the atten-
tion of clinicians to the high levels of depression and anxiety in
this patient population as they are an important determinant of
symptom reports, as well as further research on psychological and
biomedical factors that may influence the success rate of ECV.
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